-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On July 21, chemical and specialty materials company Dow Company (DOW) reported second-quarter profit and sales that beat expectations as higher selling prices helped it offset COVID-19-related lockdowns, logistics restrictions and energy and Rising raw material cos.
Dow's net income fell to $68 billion from $93 billion a year earlier, and earnings per share fell to $26 from $5 During the same period, the company's domestic market product prices rose 16%, and all market segments, business units and regions increased product pric.
Operating profit per share was $31, beating the consensus estimate of $1 Sales revenue rose 18% year-on-year to $166 billion, beating market expectations of $155 billi.
Cost of sales increased by 21%, outpacing the growth rate of sales reven.